Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cerner Co. stock logo
CERN
Cerner
$94.92
$94.92
$69.08
$95.40
$27.92B0.774.00 million shs1,320 shs
ICON Public Limited stock logo
ICLR
ICON Public
$318.72
+1.3%
$316.70
$201.35
$344.77
$26.29B1.18548,544 shs358,620 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$342.76
-3.6%
$378.36
$310.42
$415.73
$24.97B1.05524,993 shs668,064 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$119.05
-0.9%
$124.33
$102.00
$147.50
$24.49B1.031.44 million shs1.15 million shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cerner Co. stock logo
CERN
Cerner
0.00%0.00%0.00%0.00%0.00%
ICON Public Limited stock logo
ICLR
ICON Public
0.00%-0.21%+9.19%+8.89%+47.91%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.00%-2.35%-4.41%-1.77%+1.21%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.00%-0.93%+0.63%-3.63%-10.98%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cerner Co. stock logo
CERN
Cerner
2.8998 of 5 stars
0.00.02.53.91.11.72.5
ICON Public Limited stock logo
ICLR
ICON Public
3.4207 of 5 stars
2.53.00.00.02.13.33.1
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.9744 of 5 stars
3.43.03.33.23.32.53.1
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.831 of 5 stars
3.13.01.73.73.22.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cerner Co. stock logo
CERN
Cerner
N/AN/AN/AN/A
ICON Public Limited stock logo
ICLR
ICON Public
3.00
Buy$339.446.50% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.80
Moderate Buy$435.2026.97% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.29
Hold$133.2911.96% Upside

Current Analyst Ratings

Latest CERN, WST, ICLR, and ZBH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/17/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
5/3/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$137.00 ➝ $130.00
5/3/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$150.00 ➝ $155.00
5/2/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/26/2024
ICON Public Limited stock logo
ICLR
ICON Public
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$350.00 ➝ $330.00
4/26/2024
ICON Public Limited stock logo
ICLR
ICON Public
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$343.00 ➝ $349.00
4/26/2024
ICON Public Limited stock logo
ICLR
ICON Public
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$362.00 ➝ $363.00
4/4/2024
ICON Public Limited stock logo
ICLR
ICON Public
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$345.00 ➝ $362.00
4/4/2024
ICON Public Limited stock logo
ICLR
ICON Public
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$346.00
4/4/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$125.00 ➝ $130.00
4/3/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$134.00 ➝ $140.00
(Data available from 5/20/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cerner Co. stock logo
CERN
Cerner
$5.76B4.84$5.37 per share17.69$12.56 per share7.56
ICON Public Limited stock logo
ICLR
ICON Public
$8.23B3.19$19.71 per share16.17$112.02 per share2.85
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.95B8.46$9.81 per share34.94$39.31 per share8.72
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.39B3.31$12.03 per share9.90$59.76 per share1.99

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cerner Co. stock logo
CERN
Cerner
$555.60M$1.9947.7027.432.3710.15%22.86%11.75%N/A
ICON Public Limited stock logo
ICLR
ICON Public
$612.34M$8.2238.7719.121.428.30%11.70%6.25%7/24/2024 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$593.40M$7.5845.2237.426.2819.42%20.57%15.47%7/25/2024 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.02B$4.6225.7713.622.1712.93%12.70%7.43%8/6/2024 (Estimated)

Latest CERN, WST, ICLR, and ZBH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024Q1 24
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.87$1.94+$0.07$3.04$1.87 billion$1.89 billion    
4/25/2024Q1 2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.29$1.56+$0.27$1.57$670.62 million$695.40 million    
4/24/2024Q1 2024
ICON Public Limited stock logo
ICLR
ICON Public
$3.30$3.38+$0.08$4.51$2.09 billion$2.09 billion
2/21/2024Q4 2023
ICON Public Limited stock logo
ICLR
ICON Public
$3.27$3.40+$0.13$4.20$2.08 billion$2.07 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cerner Co. stock logo
CERN
Cerner
$1.081.14%N/A54.27%N/A
ICON Public Limited stock logo
ICLR
ICON Public
N/AN/AN/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.800.23%+5.81%10.55%31 Years
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.81%N/A20.78%N/A

Latest CERN, WST, ICLR, and ZBH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.22%7/31/20247/31/20248/7/2024
5/13/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.79%6/26/20246/26/20247/31/2024
2/20/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.23%4/23/20244/24/20245/1/2024
2/21/2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.77%3/27/20243/29/20244/30/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cerner Co. stock logo
CERN
Cerner
0.41
1.79
1.77
ICON Public Limited stock logo
ICLR
ICON Public
0.36
1.21
1.21
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.03
2.61
1.95
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.38
1.66
0.80

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cerner Co. stock logo
CERN
Cerner
82.23%
ICON Public Limited stock logo
ICLR
ICON Public
95.61%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Cerner Co. stock logo
CERN
Cerner
0.12%
ICON Public Limited stock logo
ICLR
ICON Public
44.00%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cerner Co. stock logo
CERN
Cerner
25,150294.10 million293.75 millionOptionable
ICON Public Limited stock logo
ICLR
ICON Public
41,10082.50 million46.20 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60072.84 million72.46 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000205.73 million204.29 millionOptionable

CERN, WST, ICLR, and ZBH Headlines

Recent News About These Companies

Zimmer Biomet Announces 2024 Investor Day
Zimmer Biomet Holdings: Moving Along
Where Zimmer Biomet stands today

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cerner logo

Cerner

NASDAQ:CERN
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.
ICON Public logo

ICON Public

NASDAQ:ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.
West Pharmaceutical Services logo

West Pharmaceutical Services

NYSE:WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Zimmer Biomet logo

Zimmer Biomet

NYSE:ZBH
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.